Key result
Various clinical risk scores, including Framingham, CHARGE-AF, and C2HEST, demonstrate validated efficacy in predicting new-onset atrial fibrillation across diverse populations.
Why the study?
Identification of incident AF is challenging, dictating the review and utilization of validated clinical risk scores in everyday clinical practice.
Do clinical risk scores accurately predict incident atrial fibrillation in individuals without previously diagnosed arrhythmias?
Do clinical risk scores accurately predict incident atrial fibrillation in individuals without previously diagnosed arrhythmias?
Various clinical risk scores can accurately predict incident atrial fibrillation, allowing for early detection and targeted preventive strategies, though score selection should be tailored to the patient's racial or ethnic background.
Validated scores may support targeted AF prevention; leaves open optimal selection by ethnicity and prospective outcome trials.
Atrial fibrillation (AF) is considered the most common sustained arrhythmia. Major cardiovascular risk factors that have been identified to initiate and perpetuate AF include age, sex, arterial hypertension, heart failure, valvular heart disease and diabetes mellitus. In the literature, several studies aimed to formulate easily - applied and accurate risk stratification scores, based on antecedent cardiovascular events, comorbidities and biomarkers for the prediction of new-onset AF. The present narrative review addresses the most universally accepted and efficient clinical scores, with an extended applicability in different populations and ages, particularly scores derived from the Framingham Heart Study, the Atherosclerosis Risk in Communities, the Malmo Diet and Cancer Study, as well as the CHARGE-AF, the CHADS2, CHA2DS2-VASc, HATCH and CH2EST scores. Identification of incident AF can be challenging, thus dictating for utilization of validated clinical instruments in everyday clinical practice.
No takes yet. Share an insight, caveat, or question.
Louka et al. (2021) conducted a review in Incident atrial fibrillation. Clinical risk scores was evaluated on Prediction of incident atrial fibrillation. Various clinical risk scores, including Framingham, CHARGE-AF, and C2HEST, demonstrate validated efficacy in predicting new-onset atrial fibrillation across diverse populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: